Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Antiangiogenic Effect of Flavonoids and Chalcones: An Update.

Mirossay L, Varinská L, Mojžiš J.

Int J Mol Sci. 2017 Dec 22;19(1). pii: E27. doi: 10.3390/ijms19010027. Review.

2.

Antiproliferative effect of β-escin - an in vitro study.

Mojžišová G, Kello M, Pilátová M, Tomečková V, Vašková J, Vaško L, Bernátová S, Mirossay L, Mojžiš J.

Acta Biochim Pol. 2016;63(1):79-87. doi: 10.18388/abp.2015_1013. Epub 2016 Jan 27.

3.

Soy and breast cancer: focus on angiogenesis.

Varinska L, Gal P, Mojzisova G, Mirossay L, Mojzis J.

Int J Mol Sci. 2015 May 22;16(5):11728-49. doi: 10.3390/ijms160511728. Review.

4.

MDR1 polymorphisms and idiopathic nephrotic syndrome in Slovak children: preliminary results.

Cizmarikova M, Podracka L, Klimcakova L, Habalova V, Boor A, Mojzis J, Mirossay L.

Med Sci Monit. 2015 Jan 6;21:59-68. doi: 10.12659/MSM.891366.

5.

MRP1 and GSTp1 expression in non-small cell lung cancer does not correlate with clinicopathological parameters: A Slovakian population study.

Rybárová S, Hodorová I, Mihalik J, Mirossay L.

Acta Histochem. 2014 Oct;116(8):1390-8. doi: 10.1016/j.acthis.2014.09.002. Epub 2014 Sep 23.

PMID:
25258012
6.

Brassinin and its derivatives as potential anticancer agents.

Chripkova M, Drutovic D, Pilatova M, Mikes J, Budovska M, Vaskova J, Broggini M, Mirossay L, Mojzis J.

Toxicol In Vitro. 2014 Aug;28(5):909-15. doi: 10.1016/j.tiv.2014.04.002. Epub 2014 Apr 18.

PMID:
24747292
7.

In vitro toxicity of camalexin derivatives in human cancer and non-cancer cells.

Pilatova M, Ivanova L, Kutschy P, Varinska L, Saxunova L, Repovska M, Sarissky M, Seliga R, Mirossay L, Mojzis J.

Toxicol In Vitro. 2013 Mar;27(2):939-44. doi: 10.1016/j.tiv.2013.01.006. Epub 2013 Jan 20.

PMID:
23339777
8.

Association between polymorphisms of XRCC1, p53 and MDR1 genes, the expression of their protein products and prognostic significance in human breast cancer.

Rybárová S, Vecanová J, Hodorová I, Mihalik J, Čižmáriková M, Mojžiš J, Solár P, Benický M, Adamkov M, Mirossay L.

Med Sci Monit. 2011 Dec;17(12):BR354-63.

9.

Prognostic significance of p53 protein and X-ray repair cross-complementing protein 1 in non-small cell lung cancer.

Rybárová S, Hodorová I, Muri J, Mihalik J, Adamkov M, Svajdler M, Piovarci D, Mirossay L.

Tumori. 2011 Jan-Feb;97(1):79-85.

PMID:
21528669
10.

Effect of selected flavones on cancer and endothelial cells.

Pilátová M, Stupáková V, Varinská L, Sarisský M, Mirossay L, Mirossay A, Gál P, Kraus V, Dianisková K, Mojzis J.

Gen Physiol Biophys. 2010 Jun;29(2):134-43.

PMID:
20577025
11.

In vitro antiproliferative and antiangiogenic effects of synthetic chalcone analogues.

Pilatova M, Varinska L, Perjesi P, Sarissky M, Mirossay L, Solar P, Ostro A, Mojzis J.

Toxicol In Vitro. 2010 Aug;24(5):1347-55. doi: 10.1016/j.tiv.2010.04.013. Epub 2010 May 5.

PMID:
20450969
12.

A new link between steroid resistance, glucocorticoid receptor and nuclear factor kappa B p65 in idiopathic nephrotic syndrome.

Szilagyi K, Podracka L, Franke NE, Mojzis J, Mirossay L.

Neuro Endocrinol Lett. 2009;30(5):629-36.

PMID:
20035271
13.

Flow cytometry analysis of neural differentiation markers expression in human glioblastomas may predict their response to chemotherapy.

Balik V, Mirossay P, Bohus P, Sulla I, Mirossay L, Sarissky M.

Cell Mol Neurobiol. 2009 Sep;29(6-7):845-58. doi: 10.1007/s10571-009-9366-6. Epub 2009 Mar 14.

PMID:
19288188
14.

Photodynamic effect of hypericin in primary cultures of human umbilical endothelial cells and glioma cell lines.

Stupáková V, Varinská L, Mirossay A, Sarisský M, Mojzis J, Dankovcík R, Urdzík P, Ostró A, Mirossay L.

Phytother Res. 2009 Jun;23(6):827-32. doi: 10.1002/ptr.2681.

PMID:
19173218
15.

Effect of flavonoids on daunorubicin-induced toxicity in H9c2 Cardiomyoblasts.

Mojzisová G, Sarisský M, Mirossay L, Martinka P, Mojzis J.

Phytother Res. 2009 Jan;23(1):136-9. doi: 10.1002/ptr.2566.

PMID:
18803248
16.

Polymorphisms of the XRCC1 and XPD genes and breast cancer risk: a case-control study.

Kipikasová L, Wolaschka T, Bohus P, Baumohlová H, Bober J, Blazejová J, Mirossay L, Sarisský M, Mirossay A, Cizmáriková M, Potoceková D, Mojzis J.

Pathol Oncol Res. 2008 Jun;14(2):131-5. doi: 10.1007/s12253-008-9034-z. Epub 2008 Apr 16.

PMID:
18415712
17.

Histomorphological changes in murine fibrosarcoma after hypericin-based photodynamic therapy.

Bobrov N, Cavarga I, Longauer F, Rybárová S, Fedorocko P, Brezáni P, Miskovský P, Mirossay L, Stubna J.

Phytomedicine. 2007 Feb;14(2-3):172-8. Epub 2006 Nov 7.

PMID:
17095201

Supplemental Content

Loading ...
Support Center